Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.
![Professor Madhukar Pai, Director of McGill Global Health Programs, speaking on camera during segment on efforts to combat drug-resistant tuberculosis](https://jnj-content-lab2.brightspotcdn.com/dims4/default/fadc85f/2147483647/strip/true/crop/3174x1785+0+30/resize/1440x810!/quality/90/?url=https%3A%2F%2Fjnj-production-jnj.s3.us-east-1.amazonaws.com%2Fbrightspot%2F8e%2F40%2F4b50f52059a7b9deae062a11649e%2Fscreen-shot-2019-05-09-at-2-58-22-pm.png)